Macrophage-specific hypoxia-inducible factor-1α deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 06 09 2018
revised: 12 03 2019
accepted: 15 03 2019
pubmed: 22 3 2019
medline: 14 4 2020
entrez: 22 3 2019
Statut: ppublish

Résumé

Chronic inflammation of the liver is often observed with obesity or type 2 diabetes. In these pathological conditions, the immunological cells, such as macrophages, play important roles in the development or growth of liver cancer. Recently, it was reported that hypoxia-inducible factor-1α (HIF-1α) is a key molecule for the acquisition of inflammatory M1 polarity of macrophages. In the present study, we examined the effects of altered macrophage polarity on obesity- and diabetes-associated liver cancer using macrophage-specific HIF-1α knockout (KO) mice. To induce liver cancer in the mice, diethylnitrosamine, a chemical carcinogen, was used. Both KO mice and wild-type littermates were fed either a high-fat diet (HFD) or normal chow. They were mainly analyzed 6 months after HFD feeding. Development of liver cancer after HFD feeding was 45% less in KO mice than in wild-type littermates mice. Phosphorylation of extracellular signal-regulated kinase 2 was also lower in the liver of KO mice. Those effects of HIF-1α deletion in macrophages were not observed in normal chow-fed mice. Furthermore, the size of liver tumors did not differ between KO and wild-type littermates mice, even those on a HFD. These results suggest that the activation of macrophage HIF-1α by HFD is involved not in the growth, but in the development of liver cancer with the enhanced oncogenic extracellular signal-regulated kinase 2 signaling in hepatocytes. The activation of macrophage HIF-1α might play important roles in the development of liver cancer associated with diet-induced obesity and diabetes.

Identifiants

pubmed: 30897274
doi: 10.1111/jdi.13047
pmc: PMC6825928
doi:

Substances chimiques

Hif1a protein, mouse 0
Hypoxia-Inducible Factor 1, alpha Subunit 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1411-1418

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 17K16143
Organisme : Japan Society for the Promotion of Science
ID : 25461333
Organisme : Japan Society for the Promotion of Science
ID : 26461327
Organisme : Japan Foundation for Applied Enzymology

Informations de copyright

© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

J Diabetes Investig. 2019 Nov;10(6):1411-1418
pubmed: 30897274
Oncogene. 2011 Apr 28;30(17):1969-83
pubmed: 21258404
Cancer Cell. 2013 Mar 18;23(3):277-86
pubmed: 23518347
J Cancer Res Clin Oncol. 2000 Jan;126(1):57-61
pubmed: 10641751
Cell Metab. 2016 Jan 12;23(1):48-62
pubmed: 26771116
Genes Dev. 2010 Mar 1;24(5):491-501
pubmed: 20194441
Oncotarget. 2016 May 24;7(21):30951-61
pubmed: 27129159
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
N Engl J Med. 2008 Nov 6;359(19):1995-2004
pubmed: 18923165
Arch Pathol Lab Med. 2000 Jul;124(7):1061-5
pubmed: 10888784
Trends Biochem Sci. 1999 Feb;24(2):68-72
pubmed: 10098401
Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103
pubmed: 15508109
Cell. 2016 Oct 6;167(2):457-470.e13
pubmed: 27667687
J Hepatol. 2015 Mar;62(3):607-16
pubmed: 25450711
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Nat Commun. 2017 Aug 18;8(1):286
pubmed: 28819169
Biochem Biophys Res Commun. 2011 Nov 25;415(3):445-9
pubmed: 22051049
Sci Rep. 2017 Jun 20;7(1):3855
pubmed: 28634350
Cancer Prev Res (Phila). 2011 Mar;4(3):396-403
pubmed: 21372039
J Hepatol. 1997 Nov;27(5):854-61
pubmed: 9382973
Hepatology. 2002 Jul;36(1):150-5
pubmed: 12085359
JAMA. 2008 Jan 2;299(1):53-60
pubmed: 18167406
J Gastroenterol. 2017 Jan;52(1):26-38
pubmed: 27714455
Hepatology. 2004 Jun;39(6):1517-24
pubmed: 15185292
Front Med. 2014 Mar;8(1):33-41
pubmed: 24234682
Cell Rep. 2017 Aug 15;20(7):1654-1666
pubmed: 28813676
Diabetes. 2009 Nov;58(11):2574-82
pubmed: 19690061
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Int J Cancer. 2011 Mar 15;128(6):1259-68
pubmed: 20506153
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Diabetes. 2016 Dec;65(12):3649-3659
pubmed: 27625023
Diabetologia. 2013 Jun;56(6):1403-12
pubmed: 23494472
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760

Auteurs

Akiko Takikawa (A)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.

Isao Usui (I)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.
Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.

Shiho Fujisaka (S)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.

Koichi Tsuneyama (K)

Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.

Keisuke Okabe (K)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.
Department of Metabolism and Nutrition, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan.

Takashi Nakagawa (T)

Department of Metabolism and Nutrition, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan.

Allah Nawaz (A)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.

Tomonobu Kado (T)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.

Teruo Jojima (T)

Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.

Yoshimasa Aso (Y)

Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi, Japan.

Yoshihiro Hayakawa (Y)

Division of Pathogenic Biochemistry, Department of Bioscience, Institute of Natural Medicine, University of Toyama, Toyama, Japan.

Kunikimi Yagi (K)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.

Kazuyuki Tobe (K)

First Department of Internal Medicine, University of Toyama, Toyama, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH